CoronaCentral

  • Dashboard

  • Trending

  • Epidemiology
    Forecasting & Modelling
    Infection Reports
    Transmission
    Contact Tracing
    Prevalence
    Prevention
    Surveillance
  • Clinical
    Clinical Reports
    Risk Factors
    Long Haul
    Pediatrics
    Medical Specialties
    Recommendations
    Imaging
    Diagnostics
    Healthcare Workers
  • Biology
    Molecular Biology
    Immunology
    Model Systems & Tools
    Non-human
  • Treatment
    Therapeutics
    Drug Targets
    Vaccines
    Clinical Trials
    Medical Devices
  • Psychology
  • Policy
    Health Policy
    Communication
    Inequality
    Education
  • Other Articles
    Reviews
    Meta-analysis
    Comments & Editorials
    CDC Weekly Reports
    Book Chapters
    News
    Non-medical
    Retractions
    Misinformation

  • Mentions
    Drugs
    Genes or Proteins
    Genetic Variation
    Locations
    Medical Specialties
    Prevention Methods
    Risk Factors
    Species
    Symptoms
    Test Types
    Transmission Types
    Vaccine Types
    Viral Lineages

  • FAQs
  • Feedback

Model Systems & Tools

Share
Research proposing new model systems, tools and assays to study the virus
Published and Preprint Papers
Filter
Species
Title
Altmetric
Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates.

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults.

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

SARS-CoV-2 productively infects human gut enterocytes.

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge (preprint)/ en

SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery.

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.

Seroconversion and fever are dose-dependent in a nonhuman primate model of inhalational COVID-19.

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

Project funded by the Chan Zuckerberg Biohub and NLM grant LM05652